3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Thrombocytopenia
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Blast Crisis
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Leukemia
3
Fanconi Anemia, Complementation Group D1
3
Breast Neoplasms
3
Anemia, Refractory, with Excess of Blasts
3
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Promyelocytic, Acute
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Intraocular Lymphoma
2
Congenital Abnormalities
2
Anemia
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Thrombocytosis
1
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Carboplatin
×
Classical hematology
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled